I am a molecular and cell biologist with specialized training in cancer genetics in both academic and industry settings. Throughout my doctoral and post-doctoral training I have maintained an interest in investigating the mechanisms through which normal cells become tumorigenic. I aim to identify new vulnerabilities in commonly mutated pathways such as the Wnt signaling pathway or telomere maintenance pathway so that we may develop novel therapeutics for tumors with limited options for treatment.

• Cancer biologist with experience designing and conducting multi-disciplinary basic and translational research projects in both academic and biopharmaceutical settings

• Experienced and comfortable working in teams, identifying and engaging scientific experts, establishing and maintaining collaborations, and supervising trainees

• Proficient at writing scientific manuscripts; skilled at preparing and delivering scientific presentations to large groups of various scientific and medical backgrounds; successful track record of grant and fellowship writing

• Adept in cellular engineering (including using of CRISPR/Cas9 genome editing, lentiviral transduction, and piggyBac transposition); primary cell and organoid culture; mouse models of cancer; cell viability and growth analysis; CoIP/ChIP; RT-qPCR and immunoblotting; TCGA/cBioPortal/UCSC Genome Browser